TrialThe British journal of dermatology2022

Difamilast, a selective phosphodiesterase 4 inhibitor, ointment in paediatric patients with atopic dermatitis: a phase III randomized double-blind, vehicle-controlled trial.

H Saeki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.